MarketPulse

preclinical data

3 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Na

SynCardia's Emperor Heart Set to Challenge Artificial Organ Market at Major Cardiology Conference

SynCardia unveils next-generation Emperor artificial heart at major cardiology conference, advancing fully implantable technology for long-term heart failure treatment.
PMIheart failuretotal artificial heart
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Cardiff Oncology's Onvansertib Shows Promise in Overcoming HER2-Low Breast Cancer Resistance

Cardiff Oncology's onvansertib shows preclinical promise in reversing HER2-low breast cancer resistance when combined with trastuzumab deruxtecan; data presentation scheduled for April 2026.
CRDFmetastatic colorectal cancerAACR Annual Meeting 2026
GlobeNewswire Inc.GlobeNewswire Inc.··Not Specified

Acrivon's AP3 Platform Shows Promise: ACR-368 Synergies Highlighted at AACR 2026

Acrivon Therapeutics presents preclinical data at AACR 2026 demonstrating strong synergy between its CHK1/2 and WEE1 inhibitors with ADC payloads and immunotherapies.
ACRVendometrial cancerAACR Annual Meeting